These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6716618)

  • 1. Status of Fluosol-DA 20%.
    Carr M
    JAMA; 1984 Jun; 251(22):2928. PubMed ID: 6716618
    [No Abstract]   [Full Text] [Related]  

  • 2. Marketing status of Fluosol.
    DasGupta AK
    JAMA; 1984 May; 251(19):2515. PubMed ID: 6716577
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracorporeal circulation with perfluorochemicals (Fluosol-DA).
    Hoshino S; Iwaya F; Igari T; Kanno M; Honda K
    J Cardiovasc Surg (Torino); 1982; 23(6):463-9. PubMed ID: 7153234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O2 and CO2 solubility of the fluorocarbon emulsion fluosol-DA 20% and O2 and CO2 dissociation curves of blood-fluosol-DA 20% mixtures.
    Grote J; Steuer K; Müller R; Söntgerath C; Zimmer K
    Adv Exp Med Biol; 1985; 191():453-61. PubMed ID: 3938602
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluosol-DA in radiation therapy.
    Lustig RA; McIntosh NL
    Prog Clin Biol Res; 1986; 211():29-38. PubMed ID: 3960931
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of moderate hemodilution with fluosol-DA or normal saline on acetaminophen disposition in the rat.
    Shrewsbury RP; White LG
    Experientia; 1990 Feb; 46(2):213-7. PubMed ID: 2303130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold protected hearts extract oxygen from Fluosol-DA during cardiopulmonary bypass.
    Gartman DM; McDonagh PF; Geha AS
    Adv Exp Med Biol; 1984; 180():443-50. PubMed ID: 6534118
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of Fluosol-DA and Hespan haemodilution on S-warfarin elimination in the rat.
    Shrewsbury RP; Hong DD
    J Pharm Pharmacol; 1990 Sep; 42(9):665-6. PubMed ID: 1706766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Fluosol-DA on radioimmunoassay results.
    Hammarstrom M; Mullins R; Sgoutas D
    Clin Chem; 1983 Jul; 29(7):1418-21. PubMed ID: 6861348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA committee questions Fluosol efficacy; US approval not imminent.
    Marwick C
    JAMA; 1983 Nov; 250(19):2585-6. PubMed ID: 6632147
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the effect of Fluosol DA (FC) against acute cerebral ischemia (author's transl)].
    Fujita K; Kusunoki T; Tamaki N; Matsumoto S
    Neurol Med Chir (Tokyo); 1981 Dec; 21(12):1209-13. PubMed ID: 6173782
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxygen supply and microcirculation of the beating dog heart after haemodilution with fluosol DA 20%.
    Harrison DK; Günther H; Vogel H; Ellermann R; Brunner M; Höper J; Kessler M
    Adv Exp Med Biol; 1985; 191():445-52. PubMed ID: 3832859
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypotensive reaction after infusion of a perfluorochemical emulsion.
    Waxman K; Cheung CK; Mason GR
    Crit Care Med; 1984 Jul; 12(7):609-10. PubMed ID: 6610534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
    Tremper KK; Anderson ST
    Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygenated fluorocarbon perfusion as treatment of acute spinal cord compression injury in dogs.
    Hansebout RR; van der Jagt RH; Sohal SS; Little JR
    J Neurosurg; 1981 Nov; 55(5):725-32. PubMed ID: 7310494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
    No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorocarbon enhancement of heterologous red cell survival: a reticuloendothelial block effect?
    Castro O; Reindorf CA; Socha WW; Rowe AW
    Int Arch Allergy Appl Immunol; 1983; 70(1):88-91. PubMed ID: 6848479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R; Peerless SJ; Hunter IG
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA; Holden SA; Jacobs JL
    Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with Fluosol-DA.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
    Prog Clin Biol Res; 1983; 122():331-42. PubMed ID: 6878375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.